Skip to main content

Table 7 Correlation between LNM, NMLNs and recurrence

From: Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma

Variates

No recurrence

Recurrence

Total

P value

LN stage

   

0.050

 pN0

581 (100.0)

0 (0.0)

581

 pN1

867 (99.4)

5 (0.6)

872

LN stage

   

0.001*

 pN1a

697 (99.9)

1 (0.1)

698

 pN1b

173 (97.7)

4 (2.3)

174

NMLNs

   

0.001*

 ≤ 5

472 (100.0)

0 (0.0)

472

 > 5

217 (97.7)

5 (2.3)

222

Area and NMLNs

    

 CLNs ≤ 5

533 (99.6)

2 (0.4)

535

0.051

 CLNs > 5

156 (98.1)

1 (1.9)

159

 LLNs ≤ 5

623 (99.8)

1 (0.2)

624

 < 0.001*

 LLNs > 5

66 (94.3)

4 (5.7)

70

  1. NMLNs number of metastatic lymph nodes, CLNs number of central cervical lymph nodes, LLNs number of lateral lymph nodes, ETE extrathyroidal extension, TNM stage tumor node metastasis stage, HT Hashimoto’s thyroiditis
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us